In this study, we examined the in vitro effects of altering metabolic conditions on IGF-II imprinting status, IGF-II / H19 mRNA, and IGF-II peptide levels in the PC3 prostate cancer cell line. The gene discussed is H19; the disease is prostate carcinoma.